CompoAtlas

Revitalize

Natural health product licensed in Canada

Licence holder
CANADIAN BIOPHARMA CORP.
NPN or DIN-HM
80136427
Status
Active licence
Licence date
28 November 2024
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one

Source : Quercétine

250 mgNot calculated
(E)-5-(p-hydroxystyryl)resorcinol

Source : Resvératrol

250 mgNot calculated
Acide 2-oxo-1,5-pentanedioïque

Source : Calcium alpha-ketoglutarate

500 mgNot calculated
2-(3,4-dihydroxyphényl)-3,7-dihydroxy-4H-1-benzopyran-4-one50 mgNot calculated
1,4-diaminobutane, N-(3-aminopropyl)-450 MicrogrammesNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Croscarmellose de sodium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Comprimé2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of/Provides antioxidants. (Provides) An antioxidant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80136427

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line